Stock Analysis on Net

Lam Research Corp. (NASDAQ:LRCX)

Cash Flow Statement
Quarterly Data

The cash flow statement provides information about a company cash receipts and cash payments during an accounting period, showing how these cash flows link the ending cash balance to the beginning balance shown on the company balance sheet.

The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.

Lam Research Corp., consolidated cash flow statement (quarterly data)

US$ in thousands

Microsoft Excel
3 months ended: Dec 24, 2023 Sep 24, 2023 Jun 25, 2023 Mar 26, 2023 Dec 25, 2022 Sep 25, 2022 Jun 26, 2022 Mar 27, 2022 Dec 26, 2021 Sep 26, 2021 Jun 27, 2021 Mar 28, 2021 Dec 27, 2020 Sep 27, 2020 Jun 28, 2020 Mar 29, 2020 Dec 29, 2019 Sep 29, 2019 Jun 30, 2019 Mar 31, 2019 Dec 23, 2018 Sep 23, 2018 Jun 24, 2018 Mar 25, 2018 Dec 24, 2017 Sep 24, 2017
Net income (loss) 954,266 887,398 802,537 814,008 1,468,507 1,425,879 1,208,934 1,021,778 1,194,830 1,179,744 1,144,657 1,071,121 869,229 823,451 696,673 574,781 514,510 465,789 541,825 547,390 568,855 533,360 1,021,146 778,800 (9,955) 590,690
Depreciation and amortization 90,941 90,479 89,604 91,663 85,414 75,751 87,932 84,228 81,705 79,874 78,397 79,453 76,389 72,912 71,083 67,248 65,530 64,664 65,408 82,274 81,794 79,805 85,119 82,236 79,898 79,142
Deferred income taxes (88,747) (24,238) (38,960) 7,195 (6,680) (133,616) (173,987) (56,878) (13,550) (13,023) (146,029) (1,136) (2,462) (1,850) (92,293) 77,508 (2,992) 70,125 (12,401) 20,797 (83,501) 212,260 19,060 (271,478) 43,204
Equity-based compensation expense 69,901 67,211 68,495 73,911 73,084 71,110 69,588 68,543 62,834 58,099 56,321 55,746 52,109 55,988 53,153 47,414 45,725 42,905 44,845 53,240 38,806 50,343 47,214 41,095 42,124 41,783
Impairment of investments 42,456
Other, net 4,182 (150) 40,761 1,559 12,729 (2,751) 33,574 (3,121) (66,514) (8,690) (27,786) (635) 6,690 4,339 (9,493) 9,172 1,248 5,701 (2,967) 1,367 (312) 3,436 11,350 22,208 3,431 11,157
Changes in operating assets and liabilities 423,297 (69,537) 160,288 738,102 (492,867) (246,785) (782,107) (356,840) 181,201 (838,480) 330,375 (39,469) (657,318) (312,329) 93,925 (157,187) (396,593) (112,020) 161,251 260,951 (67,521) 136,843 (658,731) 64,524 184,684 92,330
Adjustments to reconcile net income (loss) to net cash provided by operating activities 499,574 63,765 320,188 912,430 (328,320) (236,291) (765,000) (264,068) 245,676 (722,220) 291,278 93,959 (524,592) (180,940) 116,375 (33,353) (206,582) (1,742) 338,662 385,431 73,564 186,926 (302,788) 271,579 38,659 267,616
Net cash provided by operating activities 1,453,840 951,163 1,122,725 1,726,438 1,140,187 1,189,588 443,934 757,710 1,440,506 457,524 1,435,935 1,165,080 344,637 642,511 813,048 541,428 307,928 464,047 880,487 932,821 642,419 720,286 718,358 1,050,379 28,704 858,306
Capital expenditures and intangible assets (115,276) (76,992) (78,670) (119,457) (163,378) (140,063) (125,746) (145,368) (138,493) (136,427) (104,622) (89,596) (92,072) (62,806) (50,554) (51,375) (62,054) (39,256) (65,948) (75,522) (105,923) (56,098) (79,655) (49,057) (84,693) (60,064)
Business acquisitions, net of cash acquired (119,955) (84) (115,613)
Purchases of available-for-sale securities (299,362) (243,160) (25,297) (146,647) (790,525) (702,028) (1,750,188) (1,007,804) (270,128) (1,472,063) (147,632) (954,361) (1,190,500) (35,359) (749,829) (155,370) (125,973) (826,079) (1,425,407)
Proceeds from maturities of available-for-sales securities 15,841 7,275 26,280 32,577 17,743 14,695 23,146 33,027 27,260 106,836 430,721 662,031 691,754 597,252 483,824 211,228 351,980 600,347 70,970 30,849 294,504 70,216
Proceeds from sales of available-for-sale securities 6,837 340 345,519 541,071 656,504 515,891 362,023 178,376 415,862 169,630 270,059 457,796 337,763 327,923 228,271 514,078 67,030
Sales and maturities of available-for-sale securities (legacy) 1,496,845 2,260,859 620,378 1,307,633
Transfer of restricted cash and investments 286 (603) 61 160
Other, net (2,523) (4,966) (2,790) (4,289) (1,657) (2,435) 26,323 (28,380) (595) (4,923) (6,282) (27,997) (6,090) (1,786) (25,305) 9,988 (9,988) (540) (2,067) (1,269) (369) (3,650) (826) 638 (4,396) (10,600)
Net cash (used for) provided by investing activities (101,958) (74,683) (55,180) (84,332) (267,247) (127,803) (75,937) (94,564) 186,083 596,693 689,061 115,936 69,940 (801,666) (430,209) 169,772 (734,329) 750,682 (623,483) (1,008,171) 666,931 (672,331) 1,261,280 2,085,864 (294,813) (303,891)
Principal payments on debt, including finance lease obligations (986) (253,109) (2,061) (2,209) (17,082) (1,854) (2,032) (1,821) (1,698) (6,338) (822,046) (16,245) (4,596) (19,173) (2,948) (617,637) (17,987) (28,965) (1,157) (30,225) (6,440) (79,831) (178,279) (228,166) (47,522) (301,727)
Net proceeds from (repayments of) commercial paper (300,000) 297,850 (359,518) (86) (638,367) 199,024 798,947
Proceeds from borrowings on revolving credit facility 1,250,000 750,000
Repayment of borrowings on revolving credit facility (1,250,000) (750,000)
Proceeds from issuance of long-term debt, net of issuance costs 1,974,651 2,476,720
Treasury stock purchases (645,458) (843,238) (869,014) (581,943) (456,276) (109,779) (876,089) (1,338,006) (414,815) (1,236,753) (431,255) (1,094,571) (723,297) (448,581) (41,017) (245,433) (1,005,067) (78,132) (1,108,560) (934,637) (1,519) (1,735,895) (1,306,309) (80,105) (1,111,450) (155,385)
Dividends paid (264,414) (230,332) (232,335) (233,977) (235,980) (205,615) (208,056) (210,587) (211,216) (185,431) (185,385) (186,551) (187,927) (167,129) (167,739) (163,510) (166,721) (158,868) (164,873) (171,196) (167,907) (174,372) (82,005) (79,739) (73,127) (72,738)
Reissuance of treasury stock related to employee stock purchase plan 53,081 64,903 44,996 61,798 46,380 56,330 41,434 46,992 38,447 45,041 32,920 41,567 34,057
Proceeds from issuance of common stock 1,704 2,818 3,438 877 6,796 997 492 3,451 742 851 9,626 8,108 5,538 1,869 1,714 632 3,869 1,694 5,010 109 2,626 2,517 3,073 1,042
Other, net (3,821) (2,151) (2,917) (1,399) 1,253 (489) (152) 214 (205) 188 (269) (665) 961 (2,140) 1,592 328 (1) (13,198) (9) (2) 7 4
Net cash used for financing activities (859,894) (1,326,012) (1,037,986) (819,528) (662,212) (310,941) (1,023,534) (1,549,708) (578,103) (1,427,592) (1,381,774) (1,288,406) (865,317) (631,485) 563,400 225,462 (1,150,696) (262,096) (1,527,856) 1,643,522 (515,553) (1,990,193) (2,160,769) (186,462) (396,022) (528,804)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash 6,725 (11,031) 1,477 (2,302) 17,878 (16,925) (16,683) (5,090) (4,678) (3,776) 702 (5,756) 8,187 4,082 7,103 (10,715) 5,055 (4,193) (3,137) 4,128 (2,721) (2,311) (5,607) 4,041 842 3,317
Net change in cash, cash equivalents, and restricted cash 498,713 (460,563) 31,036 820,276 228,606 733,919 (672,220) (891,652) 1,043,808 (377,151) 743,924 (13,146) (442,553) (786,558) 953,342 925,947 (1,572,042) 948,440 (1,273,989) 1,572,300 791,076 (1,944,549) (186,738) 2,953,822 (661,289) 28,928

Based on: 10-Q (reporting date: 2023-12-24), 10-Q (reporting date: 2023-09-24), 10-K (reporting date: 2023-06-25), 10-Q (reporting date: 2023-03-26), 10-Q (reporting date: 2022-12-25), 10-Q (reporting date: 2022-09-25), 10-K (reporting date: 2022-06-26), 10-Q (reporting date: 2022-03-27), 10-Q (reporting date: 2021-12-26), 10-Q (reporting date: 2021-09-26), 10-K (reporting date: 2021-06-27), 10-Q (reporting date: 2021-03-28), 10-Q (reporting date: 2020-12-27), 10-Q (reporting date: 2020-09-27), 10-K (reporting date: 2020-06-28), 10-Q (reporting date: 2020-03-29), 10-Q (reporting date: 2019-12-29), 10-Q (reporting date: 2019-09-29), 10-K (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-Q (reporting date: 2018-12-23), 10-Q (reporting date: 2018-09-23), 10-K (reporting date: 2018-06-24), 10-Q (reporting date: 2018-03-25), 10-Q (reporting date: 2017-12-24), 10-Q (reporting date: 2017-09-24).

Cash flow statement item Description The company
Net cash provided by operating activities Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. Lam Research Corp. net cash provided by operating activities decreased from Q4 2023 to Q1 2024 but then increased from Q1 2024 to Q2 2024 exceeding Q4 2023 level.
Net cash (used for) provided by investing activities Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. Lam Research Corp. net cash (used for) provided by investing activities decreased from Q4 2023 to Q1 2024 and from Q1 2024 to Q2 2024.
Net cash used for financing activities Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. Lam Research Corp. net cash used for financing activities decreased from Q4 2023 to Q1 2024 but then increased from Q1 2024 to Q2 2024 exceeding Q4 2023 level.